Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Predictive Oncology Inc
(NQ:
POAI
)
1.680
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Predictive Oncology Inc
< Previous
1
2
3
Next >
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Present Groundbreaking PEDAL Approach at 2023 BIO International Convention
May 23, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
May 23, 2023
Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing link in drug discovery
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Releases Q1 2023 Financial Report, Business Update
May 16, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023
Company to host investor call and webcast today, May 15th, at 5:30pm EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Report First Quarter 2023 Results, Host Conference Call and Webcast
May 08, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
May 08, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member
May 03, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
May 02, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reverse Stock Split Approved, Effective April 24
April 21, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Reverse Stock Split
April 20, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Special Meeting of Stockholders Rescheduled after ‘Lack of Required Quorum’
April 18, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Adjourns Special Meeting of Stockholders
April 17, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names Oncology Translational Research Leader to Scientific Advisory Board
April 04, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
April 04, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), Integra Therapeutics Collaborate to Advance Gene Therapy
March 30, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
March 30, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Collaborates to Leverage AI for New Cancer Drugs, Announces 2022 Results
March 22, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
March 21, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Key Partnership, Declares Dividend
March 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
March 17, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
March 16, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Engages with Leading IR Consultant to Implement Comprehensive IR Effort
March 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
March 14, 2023
Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable of accelerating oncologic drug discovery and...
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Updates Shareholders, Provides Company Overview and Plans for Future
March 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Issues Letter to Shareholders
March 09, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Talks New Cvergenx Partnership During Proactive Interview
March 01, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), Cvergenx Inc. to Collaborate in Novel Approach to Personalized Radiotherapy and Drug Discovery
February 23, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
February 23, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names New Chief Business Officer
February 22, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Program to Partner Academic, Research Institutions to Assist with Drug-Discovery Initiatives
February 21, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.